CN Stock MarketDetailed Quotes

688046 GemPharmatech

Watchlist
  • 14.33
  • +0.05+0.35%
Market Closed Nov 8 15:00 CST
5.88BMarket Cap42.15P/E (TTM)

GemPharmatech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-25.83%490.78M
30.61%770.43M
25.62%561.77M
32.83%560.17M
85.94%661.7M
42.85%589.85M
143.16%447.19M
43.67%421.71M
--355.86M
135.17%412.93M
Transactional financial assets
7.66%567.25M
-35.25%402.35M
-23.88%566.22M
-19.40%637.72M
-36.45%526.87M
-28.37%621.43M
211.46%743.85M
284.48%791.24M
--829.05M
144.97%867.57M
Notes receivable and accounts receivable
33.59%376M
45.73%358.48M
43.66%319.02M
45.26%269.39M
47.67%281.44M
31.90%245.99M
44.33%222.07M
56.41%185.45M
--190.59M
56.65%186.49M
-Notes receivable
----
----
----
----
----
----
----
--236.8K
--236.8K
----
-Accounts receivable
33.59%376M
45.73%358.48M
43.66%319.02M
45.45%269.39M
47.85%281.44M
31.90%245.99M
44.33%222.07M
56.21%185.22M
--190.36M
56.65%186.49M
Other receivables (including interest and dividends)
55.24%8.41M
17.19%6.22M
8.30%5.61M
67.73%6.09M
51.71%5.42M
-87.15%5.31M
-86.48%5.18M
-90.85%3.63M
--3.57M
4,406.92%41.33M
-Accrued interest receivable
--6.33K
----
----
----
----
----
----
----
----
--254.03K
-Other receivable
----
17.19%6.22M
----
67.73%6.09M
----
-87.08%5.31M
----
-90.76%3.63M
----
4,379.22%41.08M
Advance payment
9.57%7.96M
-17.66%5.24M
20.09%6.21M
40.40%3.92M
318.60%7.26M
236.45%6.37M
88.61%5.17M
42.73%2.79M
--1.73M
-6.25%1.89M
Inventories
10.68%57.94M
11.03%53.55M
8.97%54.37M
-4.81%47.09M
12.38%52.35M
17.70%48.23M
35.46%49.89M
64.44%49.47M
--46.59M
88.88%40.98M
Non-current assets due within one year
98.99%152.38M
70.92%129.76M
271.63%120.05M
--120.1M
--76.58M
--75.92M
--32.3M
----
----
----
Other current assets
8.66%17M
167.85%18.07M
225.19%14.85M
2.51%13.04M
53.71%15.65M
-40.26%6.75M
-74.18%4.57M
-26.56%12.72M
--10.18M
-13.37%11.29M
Adjustment items of current assets
----
----
----
----
----
----
--0.01
----
----
----
Total current assets
3.10%1.68B
9.02%1.74B
9.13%1.65B
12.99%1.66B
13.20%1.63B
2.39%1.6B
124.67%1.51B
107.52%1.47B
--1.44B
127.62%1.56B
Non Current assets
Debt investment
----
----
--3.03M
----
----
----
----
----
----
----
Other equity investment
--500K
--500K
--500K
--500K
----
----
----
----
----
----
Investment real estate
--7.95M
--7.97M
----
----
----
----
----
----
----
----
Fixed assets
----
155.25%495.62M
----
150.77%486.7M
----
5.21%194.17M
----
10.30%194.08M
----
10.95%184.56M
Constru in process
----
-61.25%89.85M
----
-47.80%89.6M
----
106.82%231.84M
----
223.81%171.67M
----
1,646.50%112.1M
Productive biological assets
-13.84%6.25M
22.94%6.31M
67.36%7.47M
53.91%5.98M
70.18%7.25M
12.03%5.13M
-5.19%4.46M
3.26%3.88M
--4.26M
28.53%4.58M
Intangible assets
-3.23%45.93M
-0.92%46.93M
-0.92%47.83M
-2.42%47.34M
-2.39%47.47M
-3.79%47.36M
-2.97%48.27M
-2.06%48.51M
--48.63M
19.00%49.23M
Development expenditure
--10.92M
--7.64M
----
----
----
----
----
----
----
----
Long deferred expense
129.67%34.43M
128.97%35.76M
96.90%34.05M
90.14%36.68M
-26.97%14.99M
-29.68%15.62M
-26.88%17.29M
-21.66%19.29M
--20.53M
-1.53%22.21M
Deferred tax assets
118.00%43.29M
131.22%42.74M
109.56%36.49M
86.86%31.85M
221.10%19.86M
145.00%18.48M
242.00%17.41M
254.75%17.05M
--6.18M
26.70%7.54M
Usufruct assets
-6.34%38.87M
3.44%41.7M
5.91%44.46M
673.06%42.62M
985.16%41.5M
842.09%40.31M
791.31%41.98M
12,998.32%5.51M
--3.82M
--4.28M
Other non current assets
-98.29%3.2M
-85.45%25.98M
-67.00%75.97M
-57.55%109.6M
-35.75%186.94M
-10.36%178.5M
4,363.93%230.2M
4,458.14%258.17M
--290.98M
5,898.44%199.15M
Adjustment items of non current assets
----
----
----
--0.01
--0.01
----
----
----
----
----
Total non current assets
0.59%855.81M
8.70%870.08M
12.00%911.32M
16.95%920.07M
11.75%850.82M
30.47%800.46M
116.98%813.67M
126.40%786.71M
--761.38M
145.89%613.53M
Total assets
2.24%2.53B
8.91%2.61B
10.14%2.56B
14.37%2.58B
12.69%2.48B
10.31%2.4B
121.92%2.32B
113.74%2.25B
122.11%2.2B
132.49%2.18B
Liabilities
Current liabilities
Short term loan
-11.62%68.09M
129.19%108.11M
165.46%85.15M
523.92%76.16M
7,074.11%77.04M
4,212.35%47.17M
2,816.97%32.08M
136.88%12.21M
--1.07M
-87.90%1.09M
Notes payable and accounts payable
39.90%89.65M
65.86%94.59M
84.53%89.47M
100.56%101.86M
-4.24%64.08M
-32.99%57.03M
-10.37%48.49M
-17.73%50.79M
--66.92M
43.65%85.1M
-Accounts payable
39.90%89.65M
65.86%94.59M
84.53%89.47M
100.56%101.86M
-4.24%64.08M
-32.99%57.03M
-10.37%48.49M
-17.73%50.79M
--66.92M
56.90%85.1M
Contract liabilities
9.82%108.18M
9.73%97.84M
16.28%103.06M
21.61%108.42M
29.99%98.51M
15.87%89.17M
16.78%88.63M
17.45%89.15M
--75.78M
38.84%76.95M
Salaries payable
-15.98%37.54M
-11.92%32.28M
-7.46%27.92M
2.75%43.68M
11.82%44.68M
20.78%36.65M
26.21%30.17M
25.12%42.51M
--39.96M
44.16%30.34M
Taxs payable
-3.38%6.09M
78.63%8.44M
115.59%15.18M
146.68%16.66M
-29.21%6.3M
-63.30%4.72M
45.20%7.04M
-25.81%6.76M
--8.9M
65.44%12.87M
Other payable (including interest and dividends)
162.67%21.91M
173.82%74.57M
2.52%9.5M
2.55%10.24M
-9.34%8.34M
317.28%27.23M
42.54%9.27M
72.49%9.98M
--9.2M
61.29%6.53M
-Dividend payable
--12.25M
288.80%65.36M
----
----
----
--16.81M
----
----
----
----
-Other payable
----
-11.62%9.21M
----
2.55%10.24M
----
59.69%10.42M
----
72.49%9.98M
----
61.29%6.53M
Non current liabilities due within one year
14.20%9.92M
69.19%10.82M
88.50%10.48M
259.77%9.4M
--8.68M
--6.4M
--5.56M
--2.61M
----
----
Other current liabilities
----
----
----
----
----
----
----
-16.93%68K
----
----
Adjustment items of current assets
----
----
--0.01
--0.01
----
----
----
----
----
----
Total current liabilities
10.97%341.38M
58.98%426.64M
54.03%340.77M
71.16%366.41M
52.42%307.64M
26.06%268.36M
33.00%221.24M
11.65%214.07M
--201.84M
35.81%212.88M
Current liabilities
Deferred tax liabilities
-30.38%8.21M
-2.16%10.21M
-5.45%9.72M
-4.96%9.41M
59.16%11.8M
39.05%10.44M
51.37%10.28M
52.25%9.9M
--7.41M
26.23%7.51M
Long term deferred income
-37.38%24.81M
-36.26%26.75M
-11.13%39.37M
-16.21%41.04M
-11.56%39.62M
-24.92%41.96M
-11.29%44.3M
-2.97%48.99M
--44.8M
-15.43%55.89M
Lease liabilities
-0.89%35.82M
2.24%37.38M
2.29%38.34M
1,083.92%36.07M
731.35%36.14M
597.40%36.56M
623.14%37.48M
12,346.02%3.05M
--4.35M
--5.24M
Total non current liabilities
-21.38%68.84M
-16.43%74.34M
-5.03%87.43M
39.71%86.52M
54.80%87.56M
27.74%88.96M
41.80%92.07M
-19.61%61.93M
--56.56M
-3.32%69.65M
Total liabilities
3.80%410.23M
40.20%500.99M
36.67%428.2M
64.10%452.93M
52.94%395.2M
26.47%357.33M
35.47%313.31M
2.69%276M
6.01%258.4M
23.49%282.53M
Shareholders equity
Paid-in capital
0.00%410M
0.00%410M
0.00%410M
0.00%410M
0.00%410M
0.00%410M
13.89%410M
13.89%410M
--410M
13.89%410M
Capital reserve funds
0.23%1.26B
0.15%1.26B
0.28%1.26B
0.37%1.26B
0.36%1.26B
0.38%1.26B
353.70%1.26B
352.97%1.25B
--1.25B
352.73%1.25B
Surplus reserve funds
34.78%43.55M
34.78%43.55M
34.78%43.55M
34.78%43.55M
71.96%32.31M
71.96%32.31M
64.00%32.31M
71.96%32.31M
--18.79M
317.24%18.79M
Retained profit
13.25%432.45M
23.74%422.83M
41.45%441.33M
46.57%411.85M
48.03%381.87M
61.59%341.72M
95.92%312.02M
116.40%280.99M
--257.97M
222.65%211.48M
Less:Treasury stock
--23.87M
--23.87M
--23.87M
----
----
----
----
----
----
----
Other composite income
-32.21%886.42K
-12.35%1.22M
58.25%1.16M
19.44%1.09M
36.48%1.31M
260.27%1.4M
221.31%732.68K
239.48%908.76K
--958.09K
-3.82%387.49K
Shareholders equity without minority interests
1.94%2.12B
3.44%2.11B
6.00%2.13B
7.43%2.12B
7.34%2.08B
7.89%2.04B
146.42%2.01B
151.74%1.98B
160.03%1.94B
167.75%1.89B
Total shareholder equity
1.94%2.12B
3.44%2.11B
6.00%2.13B
7.43%2.12B
7.34%2.08B
7.89%2.04B
146.42%2.01B
151.74%1.98B
160.03%1.94B
167.75%1.89B
Adjustment items of liabilities and equity
-200.00%-0.01
----
----
----
--0.01
----
----
----
----
----
Total liabilityies and equity
2.24%2.53B
8.91%2.61B
10.14%2.56B
14.37%2.58B
12.69%2.48B
10.31%2.4B
121.92%2.32B
113.74%2.25B
122.11%2.2B
132.49%2.18B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Grant Thornton Certified Public Accountants (Special General Partnership)
--
--
--
Grant Thornton Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -25.83%490.78M30.61%770.43M25.62%561.77M32.83%560.17M85.94%661.7M42.85%589.85M143.16%447.19M43.67%421.71M--355.86M135.17%412.93M
Transactional financial assets 7.66%567.25M-35.25%402.35M-23.88%566.22M-19.40%637.72M-36.45%526.87M-28.37%621.43M211.46%743.85M284.48%791.24M--829.05M144.97%867.57M
Notes receivable and accounts receivable 33.59%376M45.73%358.48M43.66%319.02M45.26%269.39M47.67%281.44M31.90%245.99M44.33%222.07M56.41%185.45M--190.59M56.65%186.49M
-Notes receivable ------------------------------236.8K--236.8K----
-Accounts receivable 33.59%376M45.73%358.48M43.66%319.02M45.45%269.39M47.85%281.44M31.90%245.99M44.33%222.07M56.21%185.22M--190.36M56.65%186.49M
Other receivables (including interest and dividends) 55.24%8.41M17.19%6.22M8.30%5.61M67.73%6.09M51.71%5.42M-87.15%5.31M-86.48%5.18M-90.85%3.63M--3.57M4,406.92%41.33M
-Accrued interest receivable --6.33K----------------------------------254.03K
-Other receivable ----17.19%6.22M----67.73%6.09M-----87.08%5.31M-----90.76%3.63M----4,379.22%41.08M
Advance payment 9.57%7.96M-17.66%5.24M20.09%6.21M40.40%3.92M318.60%7.26M236.45%6.37M88.61%5.17M42.73%2.79M--1.73M-6.25%1.89M
Inventories 10.68%57.94M11.03%53.55M8.97%54.37M-4.81%47.09M12.38%52.35M17.70%48.23M35.46%49.89M64.44%49.47M--46.59M88.88%40.98M
Non-current assets due within one year 98.99%152.38M70.92%129.76M271.63%120.05M--120.1M--76.58M--75.92M--32.3M------------
Other current assets 8.66%17M167.85%18.07M225.19%14.85M2.51%13.04M53.71%15.65M-40.26%6.75M-74.18%4.57M-26.56%12.72M--10.18M-13.37%11.29M
Adjustment items of current assets --------------------------0.01------------
Total current assets 3.10%1.68B9.02%1.74B9.13%1.65B12.99%1.66B13.20%1.63B2.39%1.6B124.67%1.51B107.52%1.47B--1.44B127.62%1.56B
Non Current assets
Debt investment ----------3.03M----------------------------
Other equity investment --500K--500K--500K--500K------------------------
Investment real estate --7.95M--7.97M--------------------------------
Fixed assets ----155.25%495.62M----150.77%486.7M----5.21%194.17M----10.30%194.08M----10.95%184.56M
Constru in process -----61.25%89.85M-----47.80%89.6M----106.82%231.84M----223.81%171.67M----1,646.50%112.1M
Productive biological assets -13.84%6.25M22.94%6.31M67.36%7.47M53.91%5.98M70.18%7.25M12.03%5.13M-5.19%4.46M3.26%3.88M--4.26M28.53%4.58M
Intangible assets -3.23%45.93M-0.92%46.93M-0.92%47.83M-2.42%47.34M-2.39%47.47M-3.79%47.36M-2.97%48.27M-2.06%48.51M--48.63M19.00%49.23M
Development expenditure --10.92M--7.64M--------------------------------
Long deferred expense 129.67%34.43M128.97%35.76M96.90%34.05M90.14%36.68M-26.97%14.99M-29.68%15.62M-26.88%17.29M-21.66%19.29M--20.53M-1.53%22.21M
Deferred tax assets 118.00%43.29M131.22%42.74M109.56%36.49M86.86%31.85M221.10%19.86M145.00%18.48M242.00%17.41M254.75%17.05M--6.18M26.70%7.54M
Usufruct assets -6.34%38.87M3.44%41.7M5.91%44.46M673.06%42.62M985.16%41.5M842.09%40.31M791.31%41.98M12,998.32%5.51M--3.82M--4.28M
Other non current assets -98.29%3.2M-85.45%25.98M-67.00%75.97M-57.55%109.6M-35.75%186.94M-10.36%178.5M4,363.93%230.2M4,458.14%258.17M--290.98M5,898.44%199.15M
Adjustment items of non current assets --------------0.01--0.01--------------------
Total non current assets 0.59%855.81M8.70%870.08M12.00%911.32M16.95%920.07M11.75%850.82M30.47%800.46M116.98%813.67M126.40%786.71M--761.38M145.89%613.53M
Total assets 2.24%2.53B8.91%2.61B10.14%2.56B14.37%2.58B12.69%2.48B10.31%2.4B121.92%2.32B113.74%2.25B122.11%2.2B132.49%2.18B
Liabilities
Current liabilities
Short term loan -11.62%68.09M129.19%108.11M165.46%85.15M523.92%76.16M7,074.11%77.04M4,212.35%47.17M2,816.97%32.08M136.88%12.21M--1.07M-87.90%1.09M
Notes payable and accounts payable 39.90%89.65M65.86%94.59M84.53%89.47M100.56%101.86M-4.24%64.08M-32.99%57.03M-10.37%48.49M-17.73%50.79M--66.92M43.65%85.1M
-Accounts payable 39.90%89.65M65.86%94.59M84.53%89.47M100.56%101.86M-4.24%64.08M-32.99%57.03M-10.37%48.49M-17.73%50.79M--66.92M56.90%85.1M
Contract liabilities 9.82%108.18M9.73%97.84M16.28%103.06M21.61%108.42M29.99%98.51M15.87%89.17M16.78%88.63M17.45%89.15M--75.78M38.84%76.95M
Salaries payable -15.98%37.54M-11.92%32.28M-7.46%27.92M2.75%43.68M11.82%44.68M20.78%36.65M26.21%30.17M25.12%42.51M--39.96M44.16%30.34M
Taxs payable -3.38%6.09M78.63%8.44M115.59%15.18M146.68%16.66M-29.21%6.3M-63.30%4.72M45.20%7.04M-25.81%6.76M--8.9M65.44%12.87M
Other payable (including interest and dividends) 162.67%21.91M173.82%74.57M2.52%9.5M2.55%10.24M-9.34%8.34M317.28%27.23M42.54%9.27M72.49%9.98M--9.2M61.29%6.53M
-Dividend payable --12.25M288.80%65.36M--------------16.81M----------------
-Other payable -----11.62%9.21M----2.55%10.24M----59.69%10.42M----72.49%9.98M----61.29%6.53M
Non current liabilities due within one year 14.20%9.92M69.19%10.82M88.50%10.48M259.77%9.4M--8.68M--6.4M--5.56M--2.61M--------
Other current liabilities -----------------------------16.93%68K--------
Adjustment items of current assets ----------0.01--0.01------------------------
Total current liabilities 10.97%341.38M58.98%426.64M54.03%340.77M71.16%366.41M52.42%307.64M26.06%268.36M33.00%221.24M11.65%214.07M--201.84M35.81%212.88M
Current liabilities
Deferred tax liabilities -30.38%8.21M-2.16%10.21M-5.45%9.72M-4.96%9.41M59.16%11.8M39.05%10.44M51.37%10.28M52.25%9.9M--7.41M26.23%7.51M
Long term deferred income -37.38%24.81M-36.26%26.75M-11.13%39.37M-16.21%41.04M-11.56%39.62M-24.92%41.96M-11.29%44.3M-2.97%48.99M--44.8M-15.43%55.89M
Lease liabilities -0.89%35.82M2.24%37.38M2.29%38.34M1,083.92%36.07M731.35%36.14M597.40%36.56M623.14%37.48M12,346.02%3.05M--4.35M--5.24M
Total non current liabilities -21.38%68.84M-16.43%74.34M-5.03%87.43M39.71%86.52M54.80%87.56M27.74%88.96M41.80%92.07M-19.61%61.93M--56.56M-3.32%69.65M
Total liabilities 3.80%410.23M40.20%500.99M36.67%428.2M64.10%452.93M52.94%395.2M26.47%357.33M35.47%313.31M2.69%276M6.01%258.4M23.49%282.53M
Shareholders equity
Paid-in capital 0.00%410M0.00%410M0.00%410M0.00%410M0.00%410M0.00%410M13.89%410M13.89%410M--410M13.89%410M
Capital reserve funds 0.23%1.26B0.15%1.26B0.28%1.26B0.37%1.26B0.36%1.26B0.38%1.26B353.70%1.26B352.97%1.25B--1.25B352.73%1.25B
Surplus reserve funds 34.78%43.55M34.78%43.55M34.78%43.55M34.78%43.55M71.96%32.31M71.96%32.31M64.00%32.31M71.96%32.31M--18.79M317.24%18.79M
Retained profit 13.25%432.45M23.74%422.83M41.45%441.33M46.57%411.85M48.03%381.87M61.59%341.72M95.92%312.02M116.40%280.99M--257.97M222.65%211.48M
Less:Treasury stock --23.87M--23.87M--23.87M----------------------------
Other composite income -32.21%886.42K-12.35%1.22M58.25%1.16M19.44%1.09M36.48%1.31M260.27%1.4M221.31%732.68K239.48%908.76K--958.09K-3.82%387.49K
Shareholders equity without minority interests 1.94%2.12B3.44%2.11B6.00%2.13B7.43%2.12B7.34%2.08B7.89%2.04B146.42%2.01B151.74%1.98B160.03%1.94B167.75%1.89B
Total shareholder equity 1.94%2.12B3.44%2.11B6.00%2.13B7.43%2.12B7.34%2.08B7.89%2.04B146.42%2.01B151.74%1.98B160.03%1.94B167.75%1.89B
Adjustment items of liabilities and equity -200.00%-0.01--------------0.01--------------------
Total liabilityies and equity 2.24%2.53B8.91%2.61B10.14%2.56B14.37%2.58B12.69%2.48B10.31%2.4B121.92%2.32B113.74%2.25B122.11%2.2B132.49%2.18B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Grant Thornton Certified Public Accountants (Special General Partnership)------Grant Thornton Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data